IT1232677B - Composizione farmaceutica contenente ranitidina - Google Patents

Composizione farmaceutica contenente ranitidina

Info

Publication number
IT1232677B
IT1232677B IT8948382A IT4838289A IT1232677B IT 1232677 B IT1232677 B IT 1232677B IT 8948382 A IT8948382 A IT 8948382A IT 4838289 A IT4838289 A IT 4838289A IT 1232677 B IT1232677 B IT 1232677B
Authority
IT
Italy
Prior art keywords
pharmaceutical composition
composition containing
containing ranitidine
ranitidine
pharmaceutical
Prior art date
Application number
IT8948382A
Other languages
English (en)
Other versions
IT8948382A0 (it
Inventor
Christopher William Quirk
David Arthur Jackson
James Murray Cameron
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888822071A external-priority patent/GB8822071D0/en
Priority claimed from GB898905995A external-priority patent/GB8905995D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IT8948382A0 publication Critical patent/IT8948382A0/it
Application granted granted Critical
Publication of IT1232677B publication Critical patent/IT1232677B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
IT8948382A 1988-09-20 1989-10-19 Composizione farmaceutica contenente ranitidina IT1232677B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888822071A GB8822071D0 (en) 1988-09-20 1988-09-20 Medicaments
GB898905995A GB8905995D0 (en) 1989-03-15 1989-03-15 Medicaments

Publications (2)

Publication Number Publication Date
IT8948382A0 IT8948382A0 (it) 1989-10-19
IT1232677B true IT1232677B (it) 1992-03-03

Family

ID=26294415

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8948382A IT1232677B (it) 1988-09-20 1989-10-19 Composizione farmaceutica contenente ranitidina

Country Status (13)

Country Link
US (1) US5456918A (it)
JP (1) JPH0482832A (it)
AU (1) AU627775B2 (it)
BE (1) BE1002406A5 (it)
CA (1) CA1327748C (it)
CH (1) CH679373A5 (it)
DE (1) DE3931215C2 (it)
FR (1) FR2636532B1 (it)
GB (1) GB2222772B (it)
IE (1) IE60726B1 (it)
IT (1) IT1232677B (it)
NL (1) NL8902338A (it)
NZ (1) NZ230701A (it)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8904182D0 (en) * 1989-02-23 1989-04-05 Glaxo Canada Pharmaceutical compositions
EP0484106A1 (en) * 1990-11-01 1992-05-06 Merck & Co. Inc. Controlled release formulations
FR2669822B1 (fr) * 1990-12-03 1993-11-19 Fabre Medicament Pierre Composition pharmaceutique a base d'acide alginique se presentant sous forme d'une mousse.
FR2674437B1 (fr) * 1991-03-29 1993-07-09 Pf Medicament Composition pharmaceutique, utile notamment dans le traitement d'affections gastro-óoesophagiennes.
US5169638A (en) * 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
GB9221414D0 (en) * 1992-10-13 1992-11-25 Glaxo Group Ltd Pharmaceutical compositions
JPH08512321A (ja) * 1993-07-06 1996-12-24 メルク エンド カンパニー インコーポレーテッド Ｈ▲下２▼拮抗剤−アルギネート−制酸剤の組合せ物
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
FI103442B (fi) * 1993-09-24 1999-06-30 Nokia Telecommunications Oy Digitaalinen radiolinkkijärjestelmä ja radiolinkkilaite
ZA947553B (en) * 1993-09-30 1995-05-26 Glaxo Inc Ranitidine and calcium carbonate pharmaceutical combination product
ES2089949B1 (es) * 1993-10-28 1997-08-01 Robert S A Lab Nueva asociacion medicamentosa de hidroxi-bis-(18-beta-glicirretato) de aluminio y ranitidina.
CN1133558A (zh) * 1993-10-29 1996-10-16 雷克特和科尔曼产品有限公司 可发泡的明胶胶囊填充药物
WO1995011667A1 (en) * 1993-10-29 1995-05-04 R.P. Scherer Corporation Gelatin capsule fill able to foam
GB9322314D0 (en) * 1993-10-29 1993-12-15 Scherer Ltd R P Foam generating capsules
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
GB9504599D0 (en) * 1995-03-03 1995-04-26 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
WO1996039126A2 (en) * 1995-06-06 1996-12-12 Warner-Lambert Company Ranitidine salts on magnesium trisilicate as an adsorbate
SE9600071D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
AU5446798A (en) * 1996-11-27 1998-06-22 Procter & Gamble Company, The Compositions and methods for the treatment of gastrointestinal disorders
GB9715423D0 (en) * 1997-07-23 1997-09-24 Glaxo Group Ltd Aqueous compositions
HUP9701293A3 (en) * 1997-07-25 1999-08-30 Chinoin Gyogyszer Es Vegyeszet New salts without unsavoury taste and pharmaceutical compositions containing them
GB9812426D0 (en) 1998-06-10 1998-08-05 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
JP3633942B2 (ja) * 1998-09-09 2005-03-30 キユーピー株式会社 嘔吐予防食品
GB0005743D0 (en) * 2000-03-10 2000-05-03 Reckitt & Colmann Prod Ltd Pharmaceutical compositions including alginates
US6930119B2 (en) * 2002-07-17 2005-08-16 Reliant Pharmaceuticals, Inc. Liquid pharmaceutical composition
WO2005018613A1 (de) * 2003-08-26 2005-03-03 Mandapro Ag Pellets für die orale applikation von pharmazeutischen wirkstoffen
US20060094760A1 (en) * 2004-11-04 2006-05-04 Fawzy Abdel A Composition, system and method of treatment of gastrointestinal disorders with nizatidine oral solution
DE102006037298A1 (de) 2006-08-08 2008-02-14 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung, insbesondere Antazidum
WO2008106646A2 (en) * 2007-03-01 2008-09-04 Introgen Therapeutics, Inc Methods and formulations for topical gene therapy
US20100159001A1 (en) * 2008-12-19 2010-06-24 Cardinal John R Extended-Release Pharmaceutical Formulations
US20100160363A1 (en) * 2008-12-19 2010-06-24 Aaipharma Services Corp. Extended-release pharmaceutical formulations
JP5560701B2 (ja) * 2008-12-26 2014-07-30 ライオン株式会社 ラニチジン含有医薬固形製剤及びラニチジン担持粒子の製造方法
JP6270637B2 (ja) * 2014-06-06 2018-01-31 ライオン株式会社 錠剤及びその製造方法
CN115518049B (zh) * 2022-11-03 2023-02-17 则正(济南)生物科技有限公司 一种盐酸雷尼替丁胶囊及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1390683A (en) * 1972-12-18 1975-04-16 Biorex Laboratories Ltd Pharmaceutical composition
SE7504049L (sv) * 1975-04-09 1976-10-10 Haessle Ab Colonpreparation
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
GB1524740A (en) * 1976-11-09 1978-09-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions for use in the suppression of gastric reflux
US4316888A (en) * 1980-04-15 1982-02-23 Nelson Research & Development Co. Method and composition of reducing pain
EP0059221A4 (en) * 1980-09-03 1983-08-16 Kyosei Pharmaceutical Co Ltd CONNECTION FOR THE FOOD CHANNEL.
BE894285A (fr) * 1981-09-04 1983-03-02 Glaxo Group Ltd Composition pharmaceutique contenant un medicament anti-inflammatoire et de la ranitidine ou un sel de ce compose
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
US4869902A (en) * 1984-04-19 1989-09-26 Rorer Pharmaceutical Corporation Antacid composition
US4636498A (en) * 1984-10-11 1987-01-13 Pfizer Inc. Formulation of antiinflammatory drugs
NZ215069A (en) * 1985-03-01 1988-06-30 Reckitt & Colmann Prod Ltd Pharmaceutical composition with histamine h 2 -receptor antagonist
FR2585246A1 (fr) * 1985-07-26 1987-01-30 Cortial Procede d'obtention de formes pharmaceutiques solides a liberation prolongee
FR2593065B1 (fr) * 1986-01-22 1988-09-09 Smith Kline French Lab Couples effervescents, compositions effervescentes d'antagonistes h2 de l'histamine les contenant et leur preparation.
GB8618847D0 (en) * 1986-08-01 1986-09-10 Smith Kline French Lab Pharmaceutical formulations
US4814341A (en) * 1986-08-26 1989-03-21 Reiter Lawrence A 2-guanidino-4-(2-furyl) thiazoles as antiulcer agents
KR960011236B1 (ko) * 1987-05-08 1996-08-21 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 제약학적 조성물 및 고체 제형
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
HU201683B (en) * 1987-08-04 1990-12-28 Biogal Gyogyszergyar Process for producing pharmaceutical compositions for promoting healing of wounds
FR2633181B1 (fr) * 1988-06-24 1992-01-10 Glaxo Lab Sa Composition pharmaceutique a base de ranitidine et son procede de preparation

Also Published As

Publication number Publication date
IE60726B1 (en) 1994-08-10
FR2636532B1 (fr) 1993-11-19
AU627775B2 (en) 1992-09-03
IE892998L (en) 1990-03-20
DE3931215C2 (de) 1998-07-16
CH679373A5 (it) 1992-02-14
DE3931215A1 (de) 1990-03-22
AU4148989A (en) 1990-03-29
JPH0482832A (ja) 1992-03-16
GB2222772B (en) 1992-05-13
FR2636532A1 (fr) 1990-03-23
GB8921188D0 (en) 1989-11-08
BE1002406A5 (fr) 1991-01-29
GB2222772A (en) 1990-03-21
US5456918A (en) 1995-10-10
CA1327748C (en) 1994-03-15
NL8902338A (nl) 1990-04-17
IT8948382A0 (it) 1989-10-19
NZ230701A (en) 1992-01-29

Similar Documents

Publication Publication Date Title
IT1232677B (it) Composizione farmaceutica contenente ranitidina
DE10199066I1 (de) Pharmazeutische Zusammensetzung
SE8801813L (sv) Pharmaceutical composition
KR890701101A (ko) 제약학적 조성물
DE122004000023I2 (de) Pharmazeutische Zusammensetzung
DK481989A (da) Farmaceutiske formuleringer
FI895681A0 (fi) Farmaceutisk komposition foer systemisk transdermal tillfoersel.
DK489189D0 (da) Farmaceutisk praeparat
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
FI893643A (fi) Farmaceutiska kompositioner.
DE3682083D1 (de) Pharmazeutische zusammensetzungen.
DE3583765D1 (de) Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen.
IT1211967B (it) Composizione farmaceutica contenente ranitidina
DE3674040D1 (de) Pharmazeutische zusammensetzungen.
DK603988D0 (da) Farmaceutisk praeparat
DK652687D0 (da) Farmaceutisk sammensaetning omfattende azumolen
DK336489A (da) Farmaceutisk praeparat
ATA133288A (de) Pharmazeutische zusammensetzung
DE68907609D1 (de) Arzneimittelzusammensetzung.
IT1216814B (it) Composizioni farmaceutiche
DE68902056D1 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
IT1224244B (it) Composizione farmaceutica anoressizzante comprendente 5-idrossitrpofano
DE3667915D1 (de) Pharmazeutische zusammensetzung.
ATA246089A (de) Pharmazeutische zusammensetzung enthaltend phenylcarbamate
LV5734B4 (lv) Farmaceitiskas kompozicijas

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970929